SCHEMBL23826138

SCHEMBL23826138

C#Cc1cnccc1C(=O)OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.60
ALDH1A1 P00352 4/20 0.60
GLA P06280 2/20 0.60
GAA P10253 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 2/20 0.48
KMT2A Q03164 2/20 0.42
CYP46A1 Q9Y6A2 1/20 0.42
KDM4C Q9H3R0 3/20 0.41
KDM6B O15054 2/20 0.41
MEN1 O00255 1/20 0.41
KDM4A O75164 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
KDM4D Q6B0I6 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HSD17B10 Q99714 4/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9173088 0.88 KDM4E (0.54) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL29467363 0.85 ALDH1A1 (0.58) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL2847922 0.85 ALDH1A1 (0.58) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL25310017 0.82 KDM4E (0.49) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL31339220 0.82 TSHR (0.47) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL29416299 0.80 KDM4E (0.70) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL68952 0.80 KDM4E (0.70) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL30728748 0.79 KDM4E (0.64) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL1329736 0.79 KDM4E (0.64) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL116060 0.78 KDM4C (0.55) KDM4EALDH1A1GAAL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113302184-B 1,3, 4-Oxadiazolinone compounds and medicaments 日本新药株式会社 2024-11-22 CN disclosed
US-20220024921-A1 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL NIPPON SHINYAKU CO., LTD. (JP) 2022-01-27 US disclosed
EP-3882239-A1 1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE Nippon Shinyaku Co., Ltd. (JP) 2021-09-22 EP disclosed
CN-113302184-A 1,3, 4-oxadiazolinone compounds and drugs 日本新药株式会社 2021-08-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024921-A1 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL PIM1, PIM3, PIM2 KDM4E 458/4885ALDH1A1 274/4885GLA 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.